cutaneous squamous cell carcinoma research hub
6 indexed studies · 3 currently recruiting
- authorisedTherapeutic exploratory (Phase II)
A Phase II, Open-Label, Single-Arm, Multicentre Study of Immunotherapy and non-invasive response evaluation in cutaneous squamous cell carcinoma as an organ preservation strategy: a proof of concept clinical study and translational correlates - INCEPT
This study tests whether an immunotherapy medicine called Libtayo can shrink a type of skin cancer called cutaneous squamous cell carcinoma. Researchers want to see if using this drug first can help patients safely avoid having surgery, protecting healthy skin and sensitive areas like the face.
Italy - recruitingTherapeutic exploratory (Phase II)
A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell Carcinoma [CERPASS]
This study is looking at a new treatment for advanced skin cancer (cutaneous squamous cell carcinoma). It's testing a drug called cemiplimab, either alone or with another treatment called Vusolimogene oderparepvec, to see how well they shrink tumours and if they are safe.
Spain · Greece · Germany - active not recruitingPHASE2
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma
This study is looking at a new medicine called INCB099280 for people with advanced skin cancer (cutaneous squamous cell carcinoma). We want to find out if it's safe, how well people can tolerate it, and if it helps treat this type of cancer.
Australia · Brazil · Canada - recruitingNA
Thermotherapy in Addition to SOC Palliative Radiotherapy
This study looks at adding a gentle heat treatment (thermotherapy) to standard radiotherapy for certain advanced or recurrent head, neck, skin, or breast cancers. It aims to see if this combination is safe and helps shrink tumours more effectively for patients in the UK.
United Kingdom - recruiting
Cutaneous Squamous Cell Carcinoma Staging Study
This study looks at existing skin cancer cases to see how well current methods predict if the cancer might spread. The aim is to improve how we manage a type of skin cancer called cutaneous squamous cell carcinoma, helping doctors give people the best care.
United Kingdom - active not recruitingPHASE3
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
This study looks at a new drug, cemiplimab, for people who have had surgery and radiotherapy for a serious form of skin cancer (squamous cell carcinoma). We want to see if cemiplimab can stop the cancer from coming back.
United States · Australia · Belgium